Preclinical Development of Monoclonal Antibodies and Related Biologicals Report Now Available on ReportsandReports
Monoclonal antibodies form the fastest growing segment of the pharmaceutical industry, with total annual sales expected to top $50 billion in the next four years.
View full press release